Login / Signup

NEJM at ESMO - Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer.

Eric J RubinOladapo O YekuStephen Morrissey
Published in: The New England journal of medicine (2024)
Keyphrases
  • metastatic breast cancer
  • stem cells
  • cell therapy